DexCom
DXCM
229 hedge funds and large institutions have $4B invested in DexCom in 2014 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 72 increasing their positions, 86 reducing their positions, and 15 closing their positions.
233% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 15
99% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $5.59M
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
34% more capital invested
Capital invested by funds: $2.98B → $4B (+$1.02B)
15% more funds holding
Funds holding: 200 → 229 (+29)
16% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 86
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$43.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$16.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.9M |
| 4 |
Renaissance Technologies
New York
|
+$13.2M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$100M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$51.3M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$23.7M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$16.1M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$14.8M |
DXCM Hedge Fund Activity: Q4 2014 in Review
229 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2014, worth a combined $4B — up 34% from $2.98B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new DXCM positions and 15 closed out — a net gain of 35 holders — while 72 added to existing stakes and 86 trimmed.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $43.5M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $100M.
- 229 institutional investors held DexCom (DXCM) as of Q4 2014, up from 200 in Q3 2014.
- Funds reported $4B of DexCom stock for Q4 2014, up 34% quarter-over-quarter.
- 50 funds opened new DexCom positions in Q4 2014 and 15 closed out, a net change of +35 holders.
- The largest DexCom buyer in Q4 2014 was Eagle Asset Management, an estimated $43.5M added.
- The largest DexCom seller in Q4 2014 was Gilder Gagnon Howe & Co, an estimated $100M sold.
Based on aggregated 13F filings for Q4 2014.